CH BIOTECH SER

8037
0.35013.58% ( -0.055 )
Delay Closed: Nov 16, 16:08:11

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: CH BIOTECH SER(08037) the Revenue is 18.61 M (+49.71%);the EBIT is -16 M (-139.2%);the EPS is 0.0093 (+157%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B49.71%
----
----
EBIT
-0.02B139.18%
----
----
EPS
0.0093156.95%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 20, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly